Biotechnology BridgeBio Pharma Announces Early Positive Data for BBP-812, its Investigational AAV9 Gene Therapy for Canavan Disease June 22, 2022
Biotechnology Apellis Expands R&D Collaboration with Affilogic to Develop Targeted Complement Therapies for Delivery into the Brain June 22, 2022
Biotechnology Halberd Corporation Creates Subsidiary to Use Its Patented Technology to Treat Cancer (Halb) June 21, 2022
Biotechnology Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies June 21, 2022
Biotechnology BioMarin Announces the Ministry of Health, Labor and Welfare (MHLW) in Japan Granted Approval for VOXZOGO® (vosoritide) for Injection for the Treatment of Children with Achondroplasia, Whose Growth Plates are Not Closed June 21, 2022